The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, is pleased to announce that the Phase 1 trial for EBC-129 has progressed into dose expansion.
DEA Psilocybin Rescheduling Denial Overruled By Federal Appeals Court
The U.S. Court of Appeals for the Ninth Circuit ruled against the Drug Enforcement Administration (DEA) in a psilocybin rescheduling lawsuit. Washington State physician Dr. Sunil
October 31, 2023